Delivery Order SPE2DB22D1103-SPE2DB24FTNC7
Award Date
7/5/24
Potential Completion Date
7/8/24
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,878.00, is a Firm Fixed Price Delivery Order for the supply of Alfuzosin HCL ER 10 mg tablets. The award does not utilize any set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which is...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $10,164.05 firm fixed price delivery order is for the supply of 4564098079 - alfuzosin HCL ER 10 mg tablets in 90 count packages. This award is part of an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that serves as Amerisourcebergen's primary contract vehicle to provide pharmaceutical products...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,012.09 and is a Firm Fixed Price Delivery Order for the supply of Alfuzosin HCL ER 10 mg tablets. The contract has an ultimate completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.29 firm fixed price delivery order is for 90 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat benign prostatic hyperplasia. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCSED, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,711.11 firm fixed-price delivery order contract is for the supply of 4566628095 - ALFUZOSIN HCL ER 10 MG TABLET 90S, with a performance period through December 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 120 tablets of 10 mg Alfuzosin HCl extended-release tablets to the U.S. Defense Logistics Agency (DLA), a defense agency. The $1,096.04 fixed-price contract was awarded on July 9, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $8,947.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for 4566847030 - UROXATRAL 10 MG TABLET 100S, a prescription medication. The contract has a firm fixed price and has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $21,233.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award, identified as SPE2DB20D2104|SPE2DB24FV18Z, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,522.90 firm fixed-price delivery order is for the supply of 120 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat benign prostatic hyperplasia. The contract award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery...
This federal contract award is for the delivery of ALFUZOSIN ER 10 MG 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,818.77, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA, which serves as a primary...